DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

Eli Lilly & Co. (NYSE: LLY)



company name or ticker
Company Photos
(Click to zoom)

Health Care Sector Update for 01/08/2015: BIND,BIOD,PODD

Does Sanofi's $50 Million Milestone Payment to MannKind Corp. Matter?

Sanofi has made a $50 million milestone payment to MannKind, but Afrezza's success or failure is far more important to MannKind this year.

Health Care Sector Update for 01/08/2015: BIOD,BIND,PODD

Deutsche Bank, Stifel Differ On Outlook For Eli Lilly

Great News! An Exciting New Drug for Depression May Be on the Way

In phase 3 trials, Alkermes' ALKS-5461 shows promise for the treatment of depression.

Benzinga's Top Upgrades

Eli Lilly (LLY) Stock Up Today After Jefferies Upgrade

Update: Eli Lilly Lowers Earnings Estimate And Refines Strategy, But Long-Term Story Intact

Roche Collaborates with 23andMe for Parkinson's Disease - Analyst Blog

Eli Lilly and Company's (LLY) CEO, John Lechleiter Discussed 2015 Guidance - Transcript

See More Articles...